Zinc finger protein 32 promotes breast cancer stem cell-like properties through directly promoting GPER transcription

[1]  G. Ball,et al.  Low expression of G protein-coupled oestrogen receptor 1 (GPER) is associated with adverse survival of breast cancer patients , 2018, Oncotarget.

[2]  Jun S. Song,et al.  microRNA-874 suppresses tumor proliferation and metastasis in hepatocellular carcinoma by targeting the DOR/EGFR/ERK pathway , 2018, Cell Death & Disease.

[3]  Wen-Qi Jiang,et al.  Elimination of stem-like cancer cell side-population by auranofin through modulation of ROS and glycolysis , 2018, Cell Death & Disease.

[4]  Chen Ding,et al.  Breast cancer metastasis suppressor OTUD1 deubiquitinates SMAD7 , 2017, Nature Communications.

[5]  Jie Yuan,et al.  GPER promotes tamoxifen-resistance in ER+ breast cancer cells by reduced Bim proteins through MAPK/Erk-TRIM2 signaling axis. , 2017, International journal of oncology.

[6]  R. Lv,et al.  Downregulation of Rab27A contributes to metformin-induced suppression of breast cancer stem cells , 2017, Oncology letters.

[7]  C. Simón,et al.  Developmental Exposure to Endocrine Disruptors Expands Murine Myometrial Stem Cell Compartment as a Prerequisite to Leiomyoma Tumorigenesis , 2017, Stem cells.

[8]  C. Gasch,et al.  Catching moving targets: cancer stem cell hierarchies, therapy-resistance & considerations for clinical intervention , 2017, Molecular Cancer.

[9]  Xin Ma,et al.  KLF6 Suppresses Metastasis of Clear Cell Renal Cell Carcinoma via Transcriptional Repression of E2F1. , 2017, Cancer research.

[10]  M. Al-Alwan,et al.  Fascin Is Critical for the Maintenance of Breast Cancer Stem Cell Pool Predominantly via the Activation of the Notch Self‐Renewal Pathway , 2016, Stem cells.

[11]  B. Li,et al.  Upregulation and activation of δ‑opioid receptors promotes the progression of human breast cancer. , 2016, Oncology reports.

[12]  J. Zhang,et al.  ZNF32 contributes to the induction of multidrug resistance by regulating TGF-β receptor 2 signaling in lung adenocarcinoma , 2016, Cell Death and Disease.

[13]  Kai Li,et al.  Loss of ZNF32 augments the regeneration of nervous lateral line system through negative regulation of SOX2 transcription , 2016, Oncotarget.

[14]  H. Mukhtar,et al.  Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis , 2016, Oncotarget.

[15]  S. Lindsey,et al.  GPER-novel membrane oestrogen receptor. , 2016, Clinical science.

[16]  H. Klocker,et al.  GPR30 Promotes Prostate Stromal Cell Activation via Suppression of ERα Expression and Its Downstream Signaling Pathway. , 2016, Endocrinology.

[17]  H. Wakimoto,et al.  At the Crossroads of Cancer Stem Cells, Radiation Biology, and Radiation Oncology. , 2016, Cancer research.

[18]  E. Jang,et al.  Prognostic Impact and Clinicopathological Correlation of CD133 and ALDH1 Expression in Invasive Breast Cancer , 2015, Journal of breast cancer.

[19]  V. Rossi,et al.  Prostate cancer stem cells: the role of androgen and estrogen receptors , 2015, Oncotarget.

[20]  Yuquan Wei,et al.  ZNF32 protects against oxidative stress-induced apoptosis by modulating C1QBP transcription , 2015, Oncotarget.

[21]  Lara J. Monteiro,et al.  Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance , 2015, Oncogene.

[22]  Le Zhang,et al.  ZNF32 inhibits autophagy through the mTOR pathway and protects MCF-7 cells from stimulus-induced cell death , 2015, Scientific Reports.

[23]  C. Walsh,et al.  Control of a neuronal morphology program by an RNA-binding zinc finger protein, Unkempt , 2015, Genes & development.

[24]  A. Shilatifard,et al.  Zic2 is an enhancer-binding factor required for embryonic stem cell specification , 2015, Molecular cell.

[25]  Jun Yu,et al.  Poor survival is associated with the methylated degree of zinc-finger protein 545 (ZNF545) DNA promoter in gastric cancer , 2015, Oncotarget.

[26]  Zhiliang Wang,et al.  GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells , 2014, The Journal of Steroid Biochemistry and Molecular Biology.

[27]  E. Prossnitz,et al.  G Protein–Coupled Estrogen Receptor Regulates Mammary Tumorigenesis and Metastasis , 2014, Molecular Cancer Research.

[28]  Alexander M. Many,et al.  Both Canonical and Non-Canonical Wnt Signaling Independently Promote Stem Cell Growth in Mammospheres , 2014, PloS one.

[29]  Kai Li,et al.  Zinc finger protein 637 protects cells against oxidative stress-induced premature senescence by mTERT-mediated telomerase activity and telomere maintenance , 2014, Cell Death and Disease.

[30]  E. Prossnitz,et al.  Estrogen biology: New insights into GPER function and clinical opportunities , 2014, Molecular and Cellular Endocrinology.

[31]  A. Noske,et al.  The G Protein-Coupled Estrogen Receptor (GPER) Is Expressed in Two Different Subcellular Localizations Reflecting Distinct Tumor Properties in Breast Cancer , 2014, PloS one.

[32]  Zhenhua Li,et al.  GPR30 as an initiator of tamoxifen resistance in hormone-dependent breast cancer , 2013, Breast Cancer Research.

[33]  D. Kufe,et al.  MUC1-C Oncoprotein Activates ERK→C/EBPβ Signaling and Induction of Aldehyde Dehydrogenase 1A1 in Breast Cancer Cells* , 2013, The Journal of Biological Chemistry.

[34]  G. Landberg,et al.  Targeting CXCR1/2 Significantly Reduces Breast Cancer Stem Cell Activity and Increases the Efficacy of Inhibiting HER2 via HER2-Dependent and -Independent Mechanisms , 2012, Clinical Cancer Research.

[35]  R. Clarke,et al.  A Detailed Mammosphere Assay Protocol for the Quantification of Breast Stem Cell Activity , 2012, Journal of Mammary Gland Biology and Neoplasia.

[36]  A. Vivacqua,et al.  GPER mediates the Egr-1 expression induced by 17β-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells , 2012, Breast Cancer Research and Treatment.

[37]  Yuquan Wei,et al.  Establishment of a monoclonal antibody against a peptide of the novel zinc finger protein ZNF32 proved to be specific and sensitive for immunological measurements , 2012, Medical science monitor : international medical journal of experimental and clinical research.

[38]  P. Thomas,et al.  Minireview: G protein-coupled estrogen receptor-1, GPER-1: its mechanism of action and role in female reproductive cancer, renal and vascular physiology. , 2012, Endocrinology.

[39]  C. Rosano,et al.  MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells , 2012, Breast Cancer Research.

[40]  E. Prossnitz,et al.  Mechanisms of estradiol-induced insulin secretion by the G protein-coupled estrogen receptor GPR30/GPER in pancreatic beta-cells. , 2011, Endocrinology.

[41]  A. Roessner,et al.  G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer , 2011, Breast Cancer Research and Treatment.

[42]  Fang Yu,et al.  Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion , 2010, Oncogene.

[43]  N. Joste,et al.  GPR30 and estrogen receptor expression: new insights into hormone dependence of inflammatory breast cancer , 2010, Breast Cancer Research and Treatment.

[44]  M. Maggiolini,et al.  Nuclear alternate estrogen receptor GPR30 mediates 17beta-estradiol-induced gene expression and migration in breast cancer-associated fibroblasts. , 2010, Cancer research.

[45]  F. Bertucci,et al.  Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer , 2009, Clinical Cancer Research.

[46]  G. Smyth,et al.  ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. , 2009, Journal of immunological methods.

[47]  Jiang Shou,et al.  Development of resistance to targeted therapies transforms the clinically associated molecular profile subtype of breast tumor xenografts. , 2008, Cancer research.

[48]  M. Mimeault,et al.  Recent Advances on the Molecular Mechanisms Involved in the Drug Resistance of Cancer Cells and Novel Targeting Therapies , 2008, Clinical pharmacology and therapeutics.

[49]  Shulan Tian,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[50]  D. Giri,et al.  Distribution of GPR30, a Seven Membrane–Spanning Estrogen Receptor, in Primary Breast Cancer and its Association with Clinicopathologic Determinants of Tumor Progression , 2006, Clinical Cancer Research.

[51]  Danila Coradini,et al.  Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. , 2005, Cancer research.

[52]  J. Chen,et al.  LASP1 is a HIF1α target gene critical for metastasis of pancreatic cancer. , 2015, Cancer research.